日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia.

使用 GSK3β 抑制剂靶向 β-catenin 降解可诱导急性淋巴细胞白血病细胞死亡。

Cosgun Kadriye Nehir, Jumaa Huda, Robinson Mark E, Cheng Zhangliang, Oulghazi Salim, Kume Kohei, Fonseca Arce David, Agadzhanian Nikol, Kistner Klaus M, Leveille Etienne, Drivet Elsa, Yu Fang, Qian Zhijian, Song Joo Y, Chan Wing-Chung, Xu Liang, Xiao Gang, Taketo M Mark, Kothari Shalin, Davids Matthew S, Schjerven Hilde, Jellusova Julia, Müschen Markus

Discovery of Supra-Bivalent GSK3β Inhibitory Peptides Containing an ATP-Mimetic Amino Acid

发现含有ATP模拟氨基酸的超二价GSK3β抑制肽

Haslböck, Sara; Vinogradov, Alexander A; Okada, Chikako; Fujimura, Naoakusa; Aikawa, Haruo; Sengoku, Toru; Suga, Hiroaki

GSK3β-Regulated Lipolysis is Required for Histone Acetylation and Decidualization in Early Pregnancy

GSK3β调节的脂肪分解是早期妊娠中组蛋白乙酰化和蜕膜化所必需的

Wang, Peiran; Tang, Yedong; Zhao, Xueling; Ni, Yu; Zhou, Hualan; Zhang, Enhao; Li, Gaizhen; Cai, Han; Wang, Yinan; Woodgett, James R; Deng, Wenbo; Wang, Haibin; Lu, Zhongxian; Bao, Haili; Kong, Shuangbo

Age-dependent elevation of Nr4a1 attenuates PI3K/AKT/GSK3β pathway and mediates tau hyperphosphorylation and cognitive impairments.

随着年龄增长,Nr4a1 水平升高,PI3K/AKT/GSK3β 通路减弱,介导 tau 蛋白过度磷酸化和认知障碍。

Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells

更正:长期服用二甲双胍可通过抑制胶质母细胞瘤起始细胞中的 tmCLIC1 膜蛋白,经由 PP2A-GSK3β-MCL-1 通路发挥细胞抑制和细胞毒性作用。

Cianci, Francesca; Verduci, Ivan; Cazzoli, Riccardo; Cannavale, Gaetano; Rey, Guido; Veronesi, Marina; Balboni, Beatrice; Ranucci, Matteo; Palloni, Luca Maria Giovanni; Ballabio, Federico; Barsotti, Noemi; Ailuno, Giorgia; Balboni, Alice; Baldassari, Sara; Caviglioli, Gabriele; Tacconi, Carlotta; Camilloni, Carlo; Girotto, Stefania; Fantin, Alessandro; Barbieri, Federica; Cavalli, Andrea; Pasqualetti, Massimo; Florio, Tullio; Minucci, Saverio; Mazzanti, Michele

SLIT3: a novel regulator of odontogenic differentiation through Akt/GSK3β/β-catenin signaling pathway.

SLIT3:一种通过 Akt/GSK3β/β-catenin 信号通路调控牙源性分化的新型调节因子。

Jiang Lingyu, Liu Liu, Yang Fan, Cui Yujia, Xie Jing, Song Dongzhe, Fan Yi, Huang Dingming, Sun Jianxun

O-GlcNAcylation stabilizes RSK4 by antagonizing GSK3β-mediated phosphorylation to enhance radioresistance in esophageal squamous cell carcinoma

O-GlcNAc糖基化通过拮抗GSK3β介导的磷酸化作用稳定RSK4,从而增强食管鳞状细胞癌的放射抗性。

Liu, Jin; Cao, Duo; Xu, Tianqi; Xu, Junpeng; Zhang, Bowen; Yang, Xinya; Zhao, Pusong; Wang, Peng; Chen, Ligang; Jia, Qingge; Li, Mingyang

Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β

转谷氨酰胺酶2通过直接灭活GSK3β加剧卵巢癌的生存期延长

Lee, Ho; Kang, Joon Hee; Kim, Hyun Jung; Heo, Kyun; Park, Mi Kyung; Park, Jeong Hwan; Lee, Byung Il; Yook, Jong In; Kim, Soo-Youl

STARD3 regulates lysosome positioning and contacts via a GSK3-controlled phosphorylation switch.

STARD3 通过 GSK3 控制的磷酸化开关调节溶酶体的定位和接触。

Eichler Julie, Wendling Corinne, Huver Sophie, Zouiouich Mehdi, Hanss Victor, Cardinal Anna, Fimbel Victoria, Birck Catherine, McEwen Alastair G, Knorr Céline, Fromental-Ramain Catherine, Boutry Maxime, Chenard Marie-Pierre, Drin Guillaume, Tomasetto Catherine, Alpy Fabien

Corrigendum to "6-Aminonicotinamide, a G6PD inhibitor, mitigates CAPS1 reduction mediated HCC metastasis via ERK and GSK3β signals" [Neoplasia volume 70 (2025) 101239]

对“6-氨基烟酰胺,一种 G6PD 抑制剂,通过 ERK 和 GSK3β 信号减轻 CAPS1 减少介导的 HCC 转移”的更正 [Neoplasia 卷 70 (2025) 101239]

Lin, Xiahui; Xu, Yingying; Bai, Encheng; Deng, Yiran; Zhang, Wei; Xue, Ruyi; Zhang, Si; Zhang, Li; Tang, Wenqing; Dong, Ling; Chen, She